November 10, 2011

AstraZeneca and Targacept released results of the first of four phase-3 clinical trials that investigated the efficacy and tolerability of a drug that could serve as an adjunct therapy to major depressive disorder patients that had an inadequate response to initial antidepressant therapies.

June 21, 2010

The use of surrogate endpoints to help measure efficacy in clinical trials would be of...